Cargando…

A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial) – Study protocol for a randomised controlled trial

BACKGROUND: Human papillomavirus (HPV) infection is the primary cause of cervical cancer. In 2018, the World Health Organization (WHO) Director General announced his commitment to eliminate cervical cancer, with HPV vaccination as a priority. However, the costs of setting up a multi-dose HPV vaccina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baisley, Kathy J., Whitworth, Hilary S., Changalucha, John, Pinto, Ligia, Dillner, Joakim, Kapiga, Saidi, de Sanjosé, Silvia, Mayaud, Philippe, Hayes, Richard J., Lacey, Charles J., Watson-Jones, Deborah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970022/ https://www.ncbi.nlm.nih.gov/pubmed/33421649 http://dx.doi.org/10.1016/j.cct.2021.106266

Ejemplares similares

Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial
por: Baisley, Kathy, et al.
Publicado: (2022)

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial
por: Watson-Jones, Deborah, et al.
Publicado: (2022)

Does the number of doses matter? A qualitative study of HPV vaccination acceptability nested in a dose reduction trial in Tanzania
por: Mitchell, K.R., et al.
Publicado: (2021)

Reasons for Receiving or Not Receiving HPV Vaccination in Primary Schoolgirls in Tanzania: A Case Control Study
por: Watson-Jones, Deborah, et al.
Publicado: (2012)

Human Papillomavirus Vaccination in Tanzanian Schoolgirls: Cluster-Randomized Trial Comparing 2 Vaccine-Delivery Strategies
por: Watson-Jones, Deborah, et al.
Publicado: (2012)

Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development
por: Pinto, Ligia A., et al.
Publicado: (2018)

Rapid acquisition of HPV around the time of sexual debut in adolescent girls in Tanzania
por: Houlihan, Catherine F, et al.
Publicado: (2016)

An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses – A meeting report
por: Waheed, Dur-e-Nayab, et al.
Publicado: (2023)

A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania
por: Remes, Pieter, et al.
Publicado: (2012)

Feasibility and acceptability of delivering adolescent health interventions alongside HPV vaccination in Tanzania
por: Watson-Jones, Deborah, et al.
Publicado: (2016)

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
por: Tsang, Sabrina H., et al.
Publicado: (2022)

Impact of malaria and helminth infections on immunogenicity of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Tanzania()()
por: Brown, Joelle, et al.
Publicado: (2014)

Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies
por: Kreimer, Aimée R., et al.
Publicado: (2018)

HPV and cervical cancer: screening or vaccination?
por: Bosch, F X, et al.
Publicado: (2008)

HPV vaccination of immunocompromised hosts
por: Garland, S.M., et al.
Publicado: (2017)

Knowledge/attitude/practices of HPV & cervical cancer, willingness to participate in vaccine trial in preparation for HIV & HPV vaccine trials in Mali
por: Poole, D, et al.
Publicado: (2012)

Effect of school-based HPV vaccine campaigns on inequalities in uptake in France: the PrevHPV trial
por: Dussault, J, et al.
Publicado: (2023)

Quadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results From the Mid-Adult Male Vaccine Trial
por: Pinto, Ligia A., et al.
Publicado: (2016)

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
por: Elfström, K Miriam, et al.
Publicado: (2014)

Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis
por: Kechagias, Konstantinos S, et al.
Publicado: (2022)

HPV vaccination in HIV infection
por: Lacey, Charles JN.
Publicado: (2019)

High prevalence and incidence of human papillomavirus in a cohort of healthy young African female subjects
por: Watson-Jones, Deborah, et al.
Publicado: (2013)

The use of urine in the follow-up of HPV vaccine trials
por: Vorsters, Alex, et al.
Publicado: (2015)

Transmission reduction and prevention with HPV vaccination (TRAP-HPV) study protocol: a randomised controlled trial of the efficacy of HPV vaccination in preventing transmission of HPV infection in heterosexual couples
por: MacCosham, Aaron, et al.
Publicado: (2020)

Assessing the risk of cervical neoplasia in the post‐HPV vaccination era
por: Lehtinen, Matti, et al.
Publicado: (2022)

Correction: Transmission reduction and prevention with HPV vaccination (TRAP-HPV) study protocol: a randomised controlled trial of the efficacy of HPV vaccination in preventing transmission of HPV infection in heterosexual couples
Publicado: (2020)

Impact of HPV vaccination on cervical screening performance: a population-based cohort study
por: Lei, Jiayao, et al.
Publicado: (2020)

Adolescent Participation in HPV Vaccine Clinical Trials: Are Parents Willing?
por: Erves, Jennifer Cunningham, et al.
Publicado: (2017)

Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali
por: Téguété, Ibrahima, et al.
Publicado: (2017)

Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials
por: Goldstone, Stephen E.
Publicado: (2023)

HPV transcription in skin tumors
por: Hultin, Emilie, et al.
Publicado: (2019)

HPV vaccination bridges to HPV screening
por: Harper, Diane M, et al.
Publicado: (2020)

Special Issue: HPV and HPV Vaccines
por: Hibma, Merilyn
Publicado: (2022)

Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination
por: Osaghae, Ikponmwosa, et al.
Publicado: (2022)

European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination
por: von Karsa, Lawrence, et al.
Publicado: (2015)

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial
por: Lehtinen, Matti, et al.
Publicado: (2021)

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate
por: Roozendaal, Ramon, et al.
Publicado: (2020)

A feasibility trial of parent HPV vaccine reminders and phone-based motivational interviewing
por: Staras, Stephanie A. S., et al.
Publicado: (2021)

Decline in HPV-vaccination uptake in Denmark – the association between HPV-related media coverage and HPV-vaccination
por: Suppli, Camilla Hiul, et al.
Publicado: (2018)

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
por: van Poelgeest, Mariette I E, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sjle9pqn4taes6is165p13p7cc